Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Cognition in Older Patients with MS Versus MCI
Neuropsychology; ePub 2018 Jun 25; Roth, et al
Differences on neuropsychological measures can serve to distinguish amnestic mild cognitive impairment (aMCI) from multiple sclerosis (MS)-related cognitive impairment in older patients, but it is essential that these measures control for the processing speed deficit that is such a primary feature of MS. This according to a recent study that aimed to identify differences in the cognitive performance between elderly individuals with MS and those with aMCI. 3 groups, ranging in age from 60-80 years, were compared: patients with MS (n=64), patients with aMCI (n=58), and healthy adults (n=70). Participants completed a standard neuropsychological test battery that evaluated domains of attention, processing speed, executive function, memory, language, and visual spatial function. Researchers found:
- Compared to age- and gender-matched healthy controls, elderly MS patients exhibited a pattern of cognitive impairment centering on information processing speed and memory that was consistent with the deficits observed in other studies of MS patients regardless of age.
- Compared to aMCI patients, MS patients exhibited worse performance on measures of processing speed, but better performance on a measure of memory under cued conditions, a non-speeded measure of language, and measures of executive function with processing speed statistically controlled.
Roth AK, Denney DR. Burns JM, Lynch SG. Cognition in older patients with multiple sclerosis compared to patients with amnestic mild cognitive impairment and healthy older adults. [Published online ahead of print June 25, 2018]. Neuropsychology. doi:10.1037/neu0000453.